Moving to address a chronic shortage of drug treatments for cancer patients, Chinese health authorities in February announced several new policies to bring urgently needed cancer pharmaceuticals to market. The National Medical Products Administration and the National Health Commission will make it... Read More
Responding to international outcry after a Chinese scientist claimed to have helped create gene-edited babies, China has drafted a series of new regulations on gene editing. The proposed new National Health Commission rules on clinical research address gene editing, gene transfer, and... Read More
Driven by rising levels of obesity, increasingly fatty diets and heightened levels of alcoholism, heart disease has become a severe health threat in China. That is the conclusion of a new study published in the Journal of the American Medical Association, which... Read More
In its latest move to spur the availability to Chinese consumers of medicines for rare diseases and life-threatening illnesses, China is cutting taxes on some orphan drugs almost entirely. China’s State Council will cut the value-added tax (VAT) rate for some rare-disease... Read More
China’s proposed new Drug Administrative Law (DAL) would significantly strengthen safety requirements for manufacturers of drugs and vaccines, establish a readily accessible repository of drug safety information and increase civil fines for violations. According to a draft of the law, drug manufacturers... Read More
This article was originally featured on Medtech Intelligence. As Asia’s prostate cancer burden grows, so do opportunities for Western medical device companies with products to diagnose and treat the disease. Leading Western medical device firms are moving into markets across the Asian... Read More
In a sign that China intends to increase its scrutiny of foreign medical device and drug companies, its regulators are instituting a process for inspecting overseas medical manufacturing facilities. The new guidelines announced in late December by China’s National Medical Products Administration... Read More
Starting January 1, China began requiring detailed labelling and descriptions in Chinese on most medical device products sold in the country. The new regulations from China’s National Medical Products Administration, the administrative body responsible for the regulation of medical devices and pharmaceuticals... Read More
China’s National Health Commission plans to formulate the country’s first-ever dedicated treatment guidelines for rare disease patients, along with a treatment network and a patient registration system – government authorities announced in January. The announcement by the Chinese government is part of its emerging... Read More
Seeking to codify higher standards for the production, transportation and storage of vaccines, Chinese authorities in January drafted a draft Vaccine Administration Law that would tighten restrictions on vaccines. Under the draft law, companies, firms or non-profit organizations are subject to government... Read More